Page 22 - Sun Pharma

No plans to make vaccine as it requires separate infra: Sun Pharma

Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different manufacturing set-up, as per a top company official.

Sun Pharma, Ferring Pharma ink pact to introduce obstetric drug in India

The drug is indicated for the prevention of excessive bleeding in women after vaginal or caesarean childbirth

Sun Pharma dips 3% on profit booking post March quarter results

In the past three months, the stock outperformed the market by gaining nearly 20 per cent, as compared to 4.6 per cent rise in the S&P BSE Sensex, till Thursday

Sun Pharma Q4 net more than doubles to Rs 894 cr on better operational show

Low base supported overall performance; consolidated sales from operations came in at Rs 8,431 crore, up 4.4% YoY

Top headlines: Sun Pharma Q4 net rises two-fold; govt hits back at Twitter

Nifty holds 15,300, sees all-time closing high, RBI flags risk of bubble in Indian equity markets and other top news of the day

Sun Pharma Q4 net more than doubles to Rs 894 cr; declares dividend of Rs 2

Its revenue from operations came in at Rs 8,522 crore for the quarter under review, an increase of 4 per cent from the previous year

Stocks to watch: BPCL, Burger King, Eicher Motors, Sun Pharma, Pfizer

BPCL's board has approved a final dividend of Rs 58 per share, which includes a one-time special dividend of Rs 35 per equity share

Sun Pharma recalls 50,868 bottles of diabetes drug Metformin HCl in US

Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA).

Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high

Since April, the index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50; Sun Pharma scales 4-year high

Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high

Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index

Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs

Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade

Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief

Union minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage of the medicine here in Maharashtra

US FDA nod to Teva for key specialty product to weigh on Sun Pharma

Strong US portfolio, margin gains and India business growth to support stock

Stock picks by Sameet Chavan: Buy Happiest Minds, Prakash Industries

The recent price chart displays a 'Bullish Flag' breakout in Happiest Minds' stock

Stock markets start new fiscal on a high, Sensex reclaims 50,000-level

IndusInd Bank, Kotak Mahindra Bank, ICICI Bank, Sun Pharma, Bajaj Finance, and UltraTech Cement were prominent gainers

Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market

Sun Pharma, Dr Reddy's Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market, the world's largest market for pharmaceutical products, for various reasons

JB Chemicals: New launches, market share gains to drive growth

Key chronic segments have helped the JB Chemicals outperform the Indian pharma market.

Sun Pharma to launch complete range of generic anti-epilepsy drug

The firm said it plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the country at an affordable price

Stocks to watch: ITC, Sun Pharma, Grasim, Power Grid, ACC, aviation stocks

Markets regulator Sebi on Thursday allowed Thomas Cook (India) to withdraw its buyback offer because of substantial deterioration in the company's financial position

Here's a Bull Spread strategy on Sun Pharma by Nandish Shah of HDFC Sec

The stock price has witnessed running correction of 10 per cent from the recent high